A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis

Clinical trial NCT03163966 · COMPLETED

Trial details

NCT number: NCT03163966
Sponsor: Rottapharm Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis, DMARD-naive and Early Disease Patients

Start date: 2017-10-05
Primary completion: 2019-01-08
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.